Skip to content

GE HealthCare Technologies GEHC Non-Controlling Interests

Non-Controlling Interests at other companies

RadNet logo
RadNetRDNT
$272.16M+14.2%
Danaher logo
DanaherDHR
$8M0.0%
Varex Imaging Corporation logo
Varex Imaging CorporationVREX
$13.9M-2.1%

Other financials

Income statement

See full
Revenue$5.1B+7.4%
Gross profit$2.0B-1.7%
Operating income$515.0M-18.1%
Net income$389.0M-31.0%
EPS (diluted)$0.85-30.9%

Balance sheet

See full
Total debt$10.6B+15.2%
Total equity$10.7B+16.1%
Total assets$37.1B+10.5%

Cash flow

See full
Operating cash flow$290.0M+16.0%
CapEx$178.0M+17.1%
Free cash flow$112.0M+14.3%

Valuation

See full
Market cap$29.12B-13.0%
P/E15.2×+0.3×
P/S1.4×-0.3×

Profitability

See full
Gross margin39.1%-2.9pp
Operating margin12.6%-1.1pp
Net margin9.1%-1.9pp
FCF margin7.2%

Returns & leverage

See full
Return on equity19.2%-7.1pp
Debt / equity0.0×
Current ratio1.2×+0.2×

Where this comes from

Reported directly by GE HealthCare Technologies in its filing.

Tagged under the XBRL concept us-gaap:MinorityInterest.

The official record: GE HealthCare Technologies’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about GE HealthCare Technologies's non-controlling interests.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GE HealthCare Technologies's non-controlling interests?
GE HealthCare Technologies (GEHC) reported non-controlling interests of $12M in Q1 2026.
How has GE HealthCare Technologies's non-controlling interests changed year-over-year?
GE HealthCare Technologies's non-controlling interests decreased by 40.0% year-over-year, from $20M to $12M.
What is the long-term trend for GE HealthCare Technologies's non-controlling interests?
Over 3 years (2022 to 2025), GE HealthCare Technologies's non-controlling interests has grown at a 30.1% compound annual growth rate (CAGR), from $5M to $11M.
What does non-controlling interests mean?
Equity attributable to minority shareholders in subsidiaries not fully owned by the parent — their proportional claim on subsidiary net assets.